Medacta Group S.A. (MEDGF)
Medacta Group S.A. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Castel San Pietro, CH. The stock last traded at $160.00, up 0.00% on the session, giving a market capitalisation of $3.19B. On trailing twelve-month figures it carries a trailing P/E of 29.09, a net margin of 14.0%. Its beta of 0.98 implies it has historically moved less than the broad market.
Medacta Group SA is a global developer, manufacturer, and distributor of specialized orthopedic and neurosurgical medical devices. Its operations span Europe, North America, Asia-Pacific, and other international markets. The firm provides advanced solutions, such as personalized kinematic models and cutting-edge 3D planning tools, designed to support a wide array of surgical procedures, including those for the hip, knee, shoulder, spine, and sports-related injuries. Established in 1958, Medacta maintains its corporate headquarters in Castel San Pietro, Switzerland.
Medacta Group S.A. is most often compared with the following Healthcare names: